Ipathetn.com Website Review

ipath® exchange traded notes (etns) are innovative investment products from barclays that seek to provide investors with a way to. access the returns of a market or strategy, less investor fees and costs. an investment in ipath etns involves significant risks,. including possible loss of principal, and may not be suitable for all investors. for additional information regarding risks as*ociated with. the ipath® series b s&p 500® vix short-term futurestm etn is designed to provide exposure to the s&p 500® vix short-term futurestm the ipath® series b s&p gsci® crude oil total return index etn is designed to provide investors with exposure to the s&p gsci® crude barclays capital inc. acts as the issuer's agent in connection with the distribution of the ipath etns. barclays capital inc. is an affiliate of barclays bank plc and is a registered us broker-dealer regulated by the sec and the finra. exchange traded notes (etns) have become increasingly popular investment instruments, providing single-trade access to hard-to-reach as*et clas*es including commodities, volatility, and other investment strategies. learn more about the ipath etn suite of products investors in the barclays etns will not receive a schedule k-1. distributions will be reported on form 1099s. please see the applicable prospectus for a more complete discussion of the primary tax treatment and alternative tax characterizations that are possible with respect to each etn. this information should not be considered tax advice. investors are urged to consult their tax advisor with. an investment in the ipath etns described herein (the etns) involves risks, including possible loss of principal, and may not be suitable. for all investors.  selected risks are summarized here and select product specific risk factors are summarized under select risk. considerations on the relevant product pages, but we urge you to read the more detailed explanation of risks described under risk factors.